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Abstract
Background:  Mammalian hepatic lipase (HL) genes are transcribed almost exclusively in
hepatocytes. The basis for this liver-restricted expression is not completely understood. We
hypothesized that the responsible cis-acting elements are conserved among mammalian HL genes.
To identify these elements, we made a genomic comparison of 30 kb of 5'-flanking region of the
rat, mouse, rhesus monkey, and human HL genes. The in silico data were verified by promoter-
reporter assays in transfected hepatoma HepG2 and non-hepatoma HeLa cells using serial 5'-
deletions of the rat HL (-2287/+9) and human HL (-685/+13) promoter region.
Results: Highly conserved elements were present at the proximal promoter region, and at 14 and
22 kb upstream of the transcriptional start site. Both of these upstream elements increased
transcriptional activity of the human HL (-685/+13) promoter region 2–3 fold. Within the proximal
HL promoter region, conserved clusters of transcription factor binding sites (TFBS) were identified
at -240/-200 (module A), -80/-40 (module B), and -25/+5 (module C) by the rVista software. In
HepG2 cells, modules B and C, but not module A, were important for basal transcription. Module
B contains putative binding sites for hepatocyte nuclear factors HNF1α. In the presence of module
B, transcription from the minimal HL promoter was increased 1.5–2 fold in HepG2 cells, but
inhibited 2–4 fold in HeLa cells.
Conclusion:  Our data demonstrate that searching for conserved non-coding sequences by
comparative genomics is a valuable tool in identifying candidate enhancer elements. With this
approach, we found two putative enhancer elements in the far upstream region of the HL gene. In
addition, we obtained evidence that the -80/-40 region of the HL gene is responsible for enhanced
HL promoter activity in hepatoma cells, and for silencing HL promoter activity in non-liver cells.
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Background
Understanding transcriptional regulation of gene expres-
sion is a major challenge in molecular biology. In eukary-
otes, regulation of gene expression is achieved through the
complex interaction of transcription factors, which bind
to specific DNA sequence motifs. These motifs are pre-
dominantly located in the upstream region of genes. Over
the last decades, numerous transcription factors have
been identified, each with its own specific DNA binding
sequence (TFBS). Transcription factors that are potentially
involved in the regulation of a particular gene are usually
identified by the presence of the specific DNA binding
motif in the upstream regulatory region. These binding
motifs are compiled in libraries such as the Transfac data-
base [1], and programs such as MatInspector enable pat-
tern recognition with the entries in this database [2].
Unfortunately, most transcription factors bind to short,
degenerate sequences, which occur very frequently in the
eukaryotic genome. Only a very small fraction of all pre-
dicted binding sites is biologically relevant [3]. Recently,
new strategies for the ab initio identification of function-
ally significant cis-acting regulatory sequences have been
developed, based on the assumption that regulatory ele-
ments are conserved among multiple species [4-8], and
that multiple TFBS tend to specifically cluster together
[9,10]. The rVista computational tool for identification of
functional regulatory elements combines the comparative
sequence analysis of orthologous genes with the analysis
of clustering of predicted TFBS [11,12]. In this study, we
tested the validity of this approach to identify functional
TFBS for the mammalian hepatic lipase genes, by compar-
ing the in silico data with experimental promoter-reporter
assays.
Hepatic lipases (HL) are synthesized and secreted almost
exclusively by hepatocytes [13-15]. Although synthesis of
HL has been shown to occur in mouse adrenals [16], and
in mouse and human macrophages [17], this is negligible
compared to expression in liver. The HL activity present in
adrenals and ovaries [18] originates predominantly from
liver, and is transported through the circulation to these
organs [19,20]. In liver, the enzyme is bound to cell sur-
face proteoglycans within the sinusoids, from where it can
be released by heparin. Hepatic lipase plays an important
role in plasma lipoprotein metabolism and intracellular
lipid homeostasis [21], by mediating cholesterol influx
into liver cells from high-density lipoproteins (HDL), and
clearance of remnant lipoproteins from the circulation by
the liver. HL is an important determinant of plasma HDL
cholesterol levels, and is implicated in the protection
against development of premature atherosclerosis by HDL
[21]. HL gene expression in humans and rodents is regu-
lated by various hormones and nutritional states mainly
at the transcriptional level, but up- or downregulation is
limited to about two-fold [15]. In contrast to this moder-
ate regulation by hormones and nutrition, the almost
complete restriction of HL gene expression to differenti-
ated liver cells is highly conspicuous [13,14]. Several
groups have pointed to the HNF1 and HNF4α binding
sites in the proximal promoter of the HL gene to explain
this liver-specificity in humans [22-25]. Since the liver-
restricted expression is a common feature of most, if not
all, mammalian HL genes, we hypothesize that the regula-
tory elements responsible for liver-specific expression are
conserved among mammals. We therefore searched the
upstream regulatory region of the rat, mouse, rhesus mon-
key and human genes for the presence of conserved clus-
ters of TFBS motifs, and combined the in silico data with
experimental promoter-reporter assays in cultured cells of
hepatic versus non-hepatic origin. This unbiased
approach led to the identification of two putative
enhancer elements in the far upstream region, and of
highly conserved sequence modules within the proximal
promoter of the HL genes.
Results
Interspecies comparison of genomic HL sequences
Of the mammalian HL genes, genome sequence including
part of the 5'-flanking region is available for human,
chimpanzee, rhesus monkey, rat, mouse and hedgehog
(Ensembl e!42:Dec 2006)[26]. Pairwise alignment of the
HL coding sequences shows the expected, high degree of
sequence identity (Table 1). This high homology also
extends into the 5'-UTR and upstream-regulatory region,
with sequence identity ranging from 53 to 98 % over the
proximal 0.9–1.4 kb. Multiple sequence alignment of 30-
kb of the 5'-flanking region available for five HL genes (all
except for the hedgehog, which known sequence is too
short) was performed by the mVista web-tool (Fig. 1). The
chimp and macaque sequences are highly homologous to
the human sequence, as 95 % and 64 % of the 30-kb
region showed at least 95 % sequence identity over a 100-
bp window, respectively. Similarly, 5 % of the rat
sequence showed this high degree of sequence identity
with the orthologous mouse sequence. Because of the
near-identity of the chimp to the human sequence, we
only included the latter sequence in subsequent in silico
analysis. The global genomic sequence comparison
showed a particularly high conservation among the four
genes immediately upstream of the transcriptional start
site (P = 7*10-7). Three additional islands of highly signif-
icant homology (P  < 10-5) were identified further
upstream. Conservation of a 475 bp element at -14 kb was
even more significant (P = 4*10-11) than the proximal HL
promoter region (Fig. 1). The element at -22 kb (P = 2*10-
6) contained a 173 bp sequence that was completely iden-
tical among the three primate sequences.
To test the potential enhancer function of two of the most
conserved elements in the far upstream regulatory region,BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
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promoter-reporter assays were performed with human HL
promoter constructs in transiently transfected HepG2
hepatoma cells. The -14 kb element (679 bp) and the -22
kb element (387 bp) were inserted in the hHL-685Luc
plasmid. As a control, we also tested the activity of the
non-conserved -10 kb sequence (502 bp). The transcrip-
tional activity of the human HL -685/+13 promoter
region was increased 3- and 2-fold with the -14 kb and -
22 kb elements inserted in the sense orientation, respec-
tively (Fig. 2). In contrast, the -10 kb sequence slightly but
significantly reduced HL promoter activity (n = 3; P  <
0.05). Qualitatively similar effects were obtained when
the elements were inserted in the anti-sense orientation
(Fig. 2). Hence, the conserved sequences at -14 kb and -22
kb have moderate enhancer activity of the proximal HL
promoter region.
Comparative genomics of the proximal 2 kb HL upstream 
regulatory region
Submission of 2-kb upstream sequence of the rat HL gene
to the MatInspector software program (core similarity >
0.75; matrix similarity > 0.70) returned over 2000 poten-
tial TFBS, randomly distributed over the entire sequence.
A similar number of sites was predicted for the ortholo-
gous mouse, human and rhesus macaque sequences.
When we searched for clustered TFBS motifs that are con-
served between the rat and human sequence, using the
web-tool rVista, three separate modules were identified
within the proximal promoter region (Fig. 3). Module A (-
240 to -200 in the human sequence relative to the tran-
scriptional start site), for which AP1, AP2, CAAT, COUP,
C/EBP, HNF4α, PPAR and USF binding sites are pre-
dicted, corresponds to the DR1 site recently identified by
Rufibach et al. [25]. Module B (-80 to -40) potentially con-
tains AP2, CAAT, C/EBP, HNF1, HNF4, PPAR and Sp1
sites, and corresponds to the previously characterized
HNF1 site [22-24]. Module C (-25 to + 5), which may
bind AP2, C/EPB, HNF4, PPAR and USF factors, contains
the transcription start site preceded by a conserved pyrimi-
dine-rich motif, and therefore likely represents the Inr
involved in binding of the transcription initiation com-
plex. These three modules were also found to be con-
served among the human and mouse HL gene. The
human-mouse comparison revealed an additional, con-
served module (-295 to -265), with potential binding sites
for AP2, C/EBP, HNF1, HNF4, PPAR and Sp1, and which
partly overlaps the DR4-site recently described by Rufi-
bach et al. [25]. Similar results were obtained in pairwise
comparisons between orthologous sequences of macaque
and rat, and of macaque and mouse. Despite the high
homology in the intervening sequence between modules
A and B, the rVista program did not recognize conserved
clusters of TFBS among the human, macaque, rat and
mouse. Irrespective of which transcription factors actually
bind to these sites, the results of the interspecies sequence
comparison by rVista suggest that the three highly con-
served sequence modules in the proximal HL promoter
region are involved in common features of transcriptional
regulation. This is further supported by the fact that these
three modules correspond to distinct DNA footprints of
the human HL sequence in rat liver [22] and human
HepG2 cells [23].
Functional characterization of the rat HL promoter region
To corroborate the in silico results, promoter-reporter
assays were performed with promoter fragments of the rat
HL gene in transiently transfected HepG2 cells. Plasmids
were constructed with progressively 5'-deleted promoter
fragments spanning the -2287/+9 region of the rat HL
gene in front of the CAT reporter gene. Compared to the
SV40 promoter, the rHL-2287 construct showed low CAT
expression (Fig. 4). Upon deleting the 5'-end of the HL
promoter fragments to position -1048, CAT expression
became even lower, and was no longer significantly differ-
Table 1: Pairwise sequence comparison of the coding and the 5'-flanking sequence of mammalian HL genes.
upstream regulatory sequence
cDNA 
sequence
81 53 53 61 57 56 hedgehoga
79 76 86 64 55 59 mouse
79 76 92 63 57 57 rat
85 82 79 79 94 94 rhesusa
85 82 80 80 96 98 chimp
85 82 79 79 96 99 human
rabbitb hedgehog mouse rat rhesus chimp human
Sequence identity (%) was determined by pairwise alignment using the DNAMAN software package (optimal alignment; gap open penalty 10.0, gap 
extension penalty 5.0). cDNA sequence was from the translation start ATG up till the stopcodon; the upstream regulatory region was from -1400 
up till the translation start ATG.
a: Because of a gap in upstream regulatory region of the public sequence of the rhesus monkey and hedgehog HL gene (Ensembl e!42: Dec 2006), 
alignments with the rhesus and hedgehog sequence were done with the sequence from -900 and -1000 up till the start ATG, respectively.
b:the rabbit HL cDNA sequence was taken from [38].BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
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ent from promoter-less pCAT-Basic, suggesting that there
is weak enhancer activity between nucleotides -1697 and
-2287. Further deletion to position -754 slightly increased
promoter activity to levels significantly above back-
ground. Shortening the insert from -754 to -446 resulted
in a 5-fold increase in promoter activity, suggesting the
presence of a strong negative regulatory element in this
region of the rat HL gene. CAT expression was not signifi-
cantly affected by deleting the insert from -446 to -211.
The presence of the weak enhancer element between -
2287 and -1697, and the negative element between -754
and -446 corresponds to positive and negative elements in
the human HL upstream regulatory region observed by
Oka et al. [23]. We assume, therefore, that both these ele-
ments are present in homologous parts of the rat and
human gene. Indeed, the global alignment of the four spe-
cies by mVista detected homology at these parts of the
gene (Fig. 1), but homology did not exceed the 70 % over
100 bp mark used as threshold in this analysis. Appar-
ently, potentially important elements may be missed due
to the high stringency of the conservation rule in the
mVista program.
To test the importance of the conserved sequence mod-
ules within the -220 to +9 region, further 5'-deletions in
the rat HL promoter region were made (Fig. 5). Transcrip-
tional activity of the rHL-127 construct, in which module
A has been removed, was not significantly different from
that of the rHL-446 or rHL-221 constructs. Similarly,
removal of the highly conserved intervening sequence
Alignment of the 5'-flanking region of four mammalian HL genes Figure 1
Alignment of the 5'-flanking region of four mammalian HL genes . From the rat, mouse, macaque and human HL 
genes, exon-1 and 30 kb of upstream sequence was aligned by the MLAGAN algorithm of the mVista program. The sequences 
of rat (A), mouse (B) and macaque (C) are aligned to the human HL sequence (x-axis); numbering is relative to the transcrip-
tional start site. Conserved regions (> 70% homology over 100 bp window) are shaded. The boxes indicate conserved regions 
among the four sequences, as determined by RankVista (P ≤ 10-5), with the P-values given above.BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
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between modules A and B (rHL-86 and rHL-75) had no
significant effect on CAT expression. In contrast, addi-
tional removal of most of module B in rHL-39 reduced
transcriptional activity by approximately 60 %. With rHL-
23, in which the remainder of module B as well as the
putative TATA-box has been deleted, CAT expression
decreased further. Despite absence of the TATA-box, CAT
expression of the rHL-23 construct was significantly
higher than of promoter-less pCAT-Basic, which may be
due to residual promoter activity of module C.
Comparison with the proximal human HL promoter region
Similar promoter-reporter assays were performed with the
-685/+13 region of the orthologous human HL gene,
except that the luciferase gene was used as reporter (Fig.
6). Luciferase activity of the hHL-306 construct was simi-
lar to hHL-685, whereas activity of the hHL-79 construct
was slightly, but not significantly, higher. This is in line
with the rat promoter data, which show little effect of
module A, and of the intervening sequence between mod-
ules A and B, on basal transcriptional activity in HepG2
cells. The luciferase activity of the hHL-36 construct, in
which entire module B has been removed, was only 25 %
of the hHL-79 construct. The transcriptional activity of
hHL-36, which contains a bona fide TATA box and entire
module C, was 7-fold higher than background. This con-
firms that modules B and C are crucial for basal transcrip-
tional activity in HepG2 cells, with module B being most
important.
Role of module B in liver cell-specific HL transcription
To test whether modules A and B are involved in liver-spe-
cific expression of the HL gene, we compared transcrip-
tional activity of different rat HL promoter fragments in
Possible enhancer activity of the conserved sequences in the far upstream HL regulatory region Figure 2
Possible enhancer activity of the conserved sequences in the far upstream HL regulatory region. HepG2 cells 
were transiently transfected with the indicated promoter-reporter constructs. At 48 h post-transfection, transcriptional activ-
ity was determined as the firefly over renilla luciferase activity. Data are expressed as percentage of the ratio measured in the 
hHL-685luc – transfected cells. Data are means ± SD from 3–4 independent experiments, each performed in quadruplicate. 
*and **: P < 0.05; and P < 0.01, respectively.
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HepG2 cells with non-hepatic HeLa cells (Fig. 7). Pro-
moter activity in each cell line was expressed as percentage
of that of the rHL-39 construct, because this fragment rep-
resents the minimal promoter with the TATA-box and
transcription start site. In the hepatoma cells, the activity
of the rHL-75 construct was 1.5–2 fold higher than the
minimal promoter construct. In HeLa cells, contrastingly,
transcriptional activity of rHL-75 was 2–4 fold lower than
the minimal promoter construct in HeLa cells. Conse-
quently, there was a marked, 3–5-fold difference in rela-
tive promoter activity between these two cell lines. Similar
results were obtained with the longer rat HL constructs
that all contained module B. The data were minimally
affected by the simultaneous presence of module A (Fig.
7). Qualitatively similar results were obtained with
human HL promoter fragments (data not shown). We
conclude therefore, that module B plays a pivotal role in
liver-restricted expression of the HL gene, by moderately
activating transcription in liver cells, and simultaneously
suppressing activity in non-hepatic cells.
Discussion
Global alignment of the 5'-flanking region of mammalian
HL genes revealed three highly conserved elements (P ≤
10-5) that lie far upstream of the HL promoter (Fig. 1).
Two of these elements, at -14 kb and -22 kb, show moder-
Identification of functional regulatory sequences in the proximal promoter region of the HL gene by rVista Figure 3
Identification of functional regulatory sequences in the proximal promoter region of the HL gene by rVista. Of 
the proximal promoter regions of the rat and human HL genes, 600 bp were submitted to the rVista sequence analysis soft-
ware, and searched for conserved clusters of TFBS for a selection of 50 transcription factors known to be expressed in mam-
malian liver. A vertical line indicates the position of the conserved TFBS relative to the human sequence (x-axis, numbering is 
relative to the transcriptional start site). Homology between the rat and human sequence is given as described for figure 1. 
Three clusters of conserved TFBS are identified, and designated A (-240/-200), B (-80/-40) and C (-25/+5). In human-mouse 
comparison, these clusters are also evident with an additional cluster at -295/-265.BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
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ate enhancer activity in HepG2 cells. What discriminates
the conserved -14 kb and -22 kb elements from the non-
functional, non-conserved -10 kb sequence is unclear, as
all three sequences contain a similar repertoire of TFBS for
liver-expressed transcription factors (data not shown).
Further studies are required to clarify the mechanism
responsible for the enhancer activity of the two highly
conserved elements in the HL gene. The finding of two
hitherto unknown enhancers supports the hypothesis that
conserved non-coding sequences may identify functional
regulatory elements. Experimentally, we also found a pos-
itive and a negative regulatory sequence between -2.2 and
-0.4 kb of the rat HL gene that coincided with homology
peaks, but were not recognized by the Rankvista analysis
of the sequence comparison. Rubin's group recently dem-
onstrated strong in vivo enhancer activity for almost half of
the elements that are ultra-conserved among human/
mouse/rat [8,27]. Our study further illustrates the power
of the approach, and suggests that gene regulatory func-
tions may also reside in somewhat less conserved ele-
ments among mammalian genomes.
We also tested whether global genome comparisons can
also aid in identification of functional regulatory ele-
ments within highly conserved sequences, using the prox-
imal HL promoter region as a model. Within this
proximal promoter region, three modules are identified
with conserved clusters of TFBS motifs. These modules A,
B and C correspond with the previously identified regula-
tory elements DR1 [25], HNF1 [22-24] and Inr [22-24],
Effect of serial 5'-deletions of the rat HL upstream region on transcriptional activity in HepG2 cells Figure 4
Effect of serial 5'-deletions of the rat HL upstream region on transcriptional activity in HepG2 cells. HepG2 cells 
were transiently transfected with the indicated promoter-reporter constructs. At 48 h post-transfection, cells were lysed and 
expression of CAT and β-galactosidase protein was determined. Data are expressed as the ratio of CAT over β-galactosidase 
expression. Data are means ± SD from 4–7 independent experiments, each performed in triplicate. *: P < 0.05; **: P < 0.01; 
n.s.: not significant.BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
Page 8 of 13
(page number not for citation purposes)
respectively. However, we missed an additional module (-
295 to -265) that has recently been identified as a func-
tional DR4 site [25]. The cluster of TFBS within this mod-
ule appeared to be conserved among human and mouse,
but not among human and rat. Despite the relatively high
homology between the mouse and rat over the proximal
5'-flanking region of the HL gene (Table 1), the outcome
of the genomic sequence analysis differed whether the rat
or the mouse sequence was used. Hence, although search-
ing genomic sequences for conserved clusters of TFBS is a
valuable tool in predicting functionally important regula-
tory elements, this approach is sub optimal.
For two of the modules that are conserved among the four
species, a significant contribution to basal transcription
was confirmed by promoter-assays in HepG2 cells. For
module C (-25/+5), this is not surprising since it contains
the transcriptional start site itself, as well as a pyrimidine-
rich stretch that may serve as an initiator region (Inr).
Module B (-80 to -40) overlaps with a protected region in
DNAse footprinting in rat liver [22] as well as in HepG2
cells [23], and contains a HNF1 binding site that has been
implicated in liver-specific expression of the human HL
gene by other groups [22-24]. Experimentally, we could
not confirm a major role for module A (-240 to -200) in
determining basal transcription activity in HepG2 cells.
This is surprising since it corresponds to a functional DR1
site [25], and perfectly matches with a protected region in
DNAse footprinting in rat liver and human HepG2
nuclear extracts [22,23], suggesting that this part of the HL
promoter is occupied by transcription factors under basal
conditions. Similarly, we could not confirm the role of the
Effect of serial 5'-deletions of the rat HL promoter region on transcriptional activity in HepG2 cells Figure 5
Effect of serial 5'-deletions of the rat HL promoter region on transcriptional activity in HepG2 cells. Experiments 
were performed as described in the legends to figure 4. Data were expressed as percentage of the ratio measured in the rHL-
446 CAT – transfected cells, and are means ± SD from 3–5 independent experiments, each performed in triplicate. *: P < 0.05; 
n.s.: not significant.BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
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DR4 module (-295 to -265) conserved among human and
mouse, in basal transcriptional activity in HepG2 cells.
We propose, therefore, that this part of the HL promoter
region is involved in modulation of gene transcription
under different hormonal or nutritional conditions.
We show here that the conserved module B (-80 to -40)
plays a dual role in mediating liver-restricted transcription
of the HL gene. On the one hand, the module mediates
moderate stimulation of minimal promoter activity in
liver-derived HepG2 cells, and on the other hand, it medi-
ates inhibition of minimal promoter activity in the non-
hepatic HeLa cells. Of the potential TFBS identified in
module B, the liver-enriched HNF1 is a likely candidate
for effecting the liver-specific activation of the HL pro-
moter. Other groups have already suggested an important
role for the HNF1 binding site [22-24], and in vitro HNF1
binding to this sequence has been demonstrated by
gelshift assays [24]. Furthermore, HNF1α knockout mice
have 3.4 fold lower HL mRNA levels than control mice
[28]. In primary hepatocytes, HL secretion increases with
HNF1α gene dosage [28]. However, HL mRNA and HL
secretion are not completely lost by HNF1α knockout,
indicating that HNF1α is not the only transcription factor
determining HL expression in liver. HL secretion was only
observed with hepatoma cell lines that express HNF1α or
HNF1β mRNA [24], but not all cell lines with detectable
HNF1α or -β expression do also secrete HL. In fact, HL
secretion correlated with expression of HNF4 rather than
with HNF1 mRNA [24]. The HNF4α gene itself is a target
Effect of serial 5'-deletions of the human HL promoter region on transcriptional activity in HepG2 cells Figure 6
Effect of serial 5'-deletions of the human HL promoter region on transcriptional activity in HepG2 cells. HepG2 
cells were transiently transfected with the indicated promoter-reporter constructs. At 48 h post-transfection, transcriptional 
activity was determined as the firefly over renilla luciferase activity. Data are expressed as percentage of the ratio measured in 
the hHL-685luc – transfected cells. Data are means ± SD from 4 independent experiments, each performed in quadruplicate. *: 
P < 0.05; n.s.: not significant.BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
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of HNF1α [29]. Since potential HNF4α binding sites were
detected in the conserved module A (as well as in the -
295/-265 module), the liver-specific stimulation of HL
promoter activity may well be mediated by HNF4α. In
fact, HNF4α is bound to the promoter regions of almost
half of the actively transcribed genes in human liver [29]
and therefore contributes to a large fraction of liver-spe-
cific gene expression. Sequence modules that contain
both HNF1 and HNF4 binding sites are among the strong-
est predictors of liver-specific transcription [10]. Rufibach
et al. [25] proposed that HNF1α and HNF4α independ-
ently and additively activate HL promoter activity. Which
transcription factor(s) mediate inhibition of minimal pro-
moter activity in cells of non-hepatic origin, remain(s)
unknown at present.
Conclusion
In summary, we have shown here that a global multispe-
cies comparison of non-coding sequences, followed by a
search for conserved clusters of TFBS, has predicted the
most important sequences involved in basal transcription
of the HL gene. This in silico analysis does not identify all
regulatory sequences in a particular gene, but enables the
intelligent design of experiments towards identification of
functional cis-regulatory elements and transactivating fac-
tors in gene regulation. This study illustrates the power of
Transcriptional activity of the rat proximal HL promoter region in HepG2 and HeLa cells Figure 7
Transcriptional activity of the rat proximal HL promoter region in HepG2 and HeLa cells. HepG2 (hatched bars) 
and HeLa cells (open bars) were transiently transfected with the indicated promoter-reporter constructs. At 48 h post-trans-
fection, transcriptional activity was determined as the ratio of CAT over β-galactosidase expression level. Data are expressed 
as percentage of the ratio measured in the rHL-39 CAT – transfected cells. Data are means ± SD from 3 independent experi-
ments, each performed in triplicate. *,+: P < 0.05 compared to 100% in HepG2 and HeLa cells, respectively.BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
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comparative genomics in the identification of TFBS that
are functional in gene expression.
Methods
Database analysis
The annotated data of the mammalian genome sequence
projects were accessed through the Ensembl genome
server (e!42: Dec 2006) [30]. The exon-1 and 5'-upstream
regulatory sequence of the hepatic lipase gene was availa-
ble only for human (ENSG00000166035), rat
(ENSRNOG00000015747), mouse
(ENSMUSG00000032207), hedgehog
(ENSETEG00000015177), chimpanzee
(ENSPTRG00000007115) and rhesus macaque
(ENSMMUG00000009566). Multiple sequence align-
ment was performed with DNAMAN software package
version 3.2 (Lynnon BioSoft, Quebec, Canada). Global
sequence alignments were performed with the publicly
available web-based tool mVista [12,31] using the MLA-
GAN algorithm. A search for potential TFBS in the
upstream regulatory region of a particular HL gene was
performed online at Genomatix using the MatInspector
program [2,32]. Clusters of TFBS that are conserved
among the rat, mouse, human and macaque HL promoter
regions were identified by the publicly available web-tool
rVista [11,12,31].
Isolation of exon-1 and the 5'-flanking region of the rat HL 
gene
A rat genomic library in λ DASH II (Stratagene, La Jolla,
CA, USA) was used for isolation of the HL promoter
region, using a HL cDNA probe corresponding to exons-1
and -2. The probe was generated by RT-PCR on 1 μg rat
liver RNA using the oligonucleotides (5'-GGT AAG ACG
AGA GAC ATG G-3', nt 1–19; numbering according to
[33]) and (5'-CCC GTG GAT GAT CAT GAC AA-3', nt
285–266) as forward and reverse primers, respectively.
The RT-PCR product was isolated by agarose gel electro-
phoresis, and radiolabeled using [α32-P]dCTP and the
Megaprime kit from Amersham (Amersham, UK). Filters
containing 106  plaques were hybridized overnight at
42°C with 50 ng of the labeled cDNA probe in hybridiza-
tion buffer (50 % (v/v) formamide, 0.5 % (w/v) SDS, 0.1
mg/ml denaturated herring sperm DNA and 2 × PIPES
buffer; [34]). After washing in 0.2 × sodium chloride/
sodium citrate/0.5% SDS at 65°C for 5 min, the filters
were exposed to autoradiography film. Two positive
clones were identified, which were plaque-purified three
times. One of these clones was selected for further analy-
sis. Phage DNA was isolated and digested with EcoRI. A 6
kb fragment [35] was subcloned into pBluescript KS-
(pBsE6) and its identity with the 5'-regulatory region of
the rat HL gene was verified by sequence analysis.
Construction of reporter plasmids
The clone in pBluescript containing the 6 kb EcoRI frag-
ment of the rat HL gene (pBsE6) was used to generate pro-
moter-reporter constructs in pCAT-Basic (Promega,
Madison, WI, USA). By digestion with PstI and XbaI, a
1.85-kb PstI/PstI, a 0.32-kb PstI/XbaI and a 0.15-kb XbaI/
XbaI fragment was isolated. First, the 0.32-kb PstI/XbaI (-
446/-127; numbering according to [35]) fragment was
cloned into pCAT-Basic. From this construct, the rHL-446
CAT plasmid was generated by insertion of the 0.15-kb
XbaI (-127/+9) fragment. Subsequently, rHL-2287 CAT
was generated by insertion of the 1.85-kb PstI (-2287/-
446) fragment into rHL-446. The rHL-127 CAT construct
was made by subcloning the 0.15-kb XbaI (-127/+9) frag-
ment into pCAT-Basic.
From the rHL-2287 CAT vector, the 5'-truncated rHL-
1697, rHL-1041 and rHL-747 constructs were generated
by PCR using HindIII-restriction site-containing oligonu-
cleotides 3F, 4F and 5F as upstream primer, respectively,
and the CAT-gene specific oligonucleotide CATrev2 as
downstream-primer (Table 2). After digestion of the PCR
products with HindIII and PstI, the DNA fragments were
purified by electrophoresis through agarose gel, and sub-
sequently ligated into the rHL-446 CAT plasmid that had
been digested with the same restriction enzymes. Simi-
larly, the rHL-211 construct was generated from the rHL-
446 CAT by PCR using oligonucleotides 9F and CATrev2
as upstream and downstream primer, respectively, fol-
lowed by ligation into the HindIII and XbaI sites of rHL-
446 CAT. Finally, the rHL-75, rHL-39 and rHL-23 con-
structs were generated from pBsE6 using 7F, 6F and 11F as
upstream, and T3Primer as downstream primer, respec-
tively, followed by digestion and ligation into the HindIII
and PstI sites of pCAT-Basic; subsequently, the resulting
plasmids were digested with XbaI followed by self-liga-
tion.
Human HL promoter constructs were made in the pGL3-
Basic luciferase reporter plasmid (Promega, Madison, WI,
USA), starting from the hHL(-685/+13)-CAT plasmid
described previously [36]. An upstream SacI restriction
site was introduced by PCR using the HHL-685Sac primer
(Table 2) and the downstream HHL+13Xba primer. After
digestion with SacI and XbaI, the gel-purified DNA prod-
ucts were ligated into the SacI and NheI sites of pGL3, thus
generating the hHL-685Luc plasmid. Similarly, hHL-
306Luc, hHL-79Luc and hHL-36Luc plasmids were gener-
ated by using HHL-306Nhe, HHL-79Kpn, and HHL-
36Kpn as upstream primers, respectively.
To test the enhancer activity of conserved upstream
sequences, the -14 kb, -22 kb and -10 kb elements were
inserted into the enhancer site of the hHL-685Luc plasmid
using the BamHI  and  SalI  restriction sites. HumanBMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
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genomic DNA was isolated from a buffy coat, and the -14
kb, -22 kb and -10 kb elements were PCR amplified using
specific primers (Table 2). The PCR products were cloned
into the pGEM T-easy vector (ProMega, Madison, WI,
USA). After digestion of the plasmids with BamHI and
SalI, the inserts were cloned into hHL-685Luc in either
sense or anti-sense orientation.
All clones were verified by DNA sequencing using the
Thermo-sequenase dye terminator kit (Amersham, UK)
and the ABI 377 sequencer (Applied Biosystems, Foster
City, CA, USA).
Promoter reporter assays
HepG2 hepatoma cells and HeLa cells were cultured at
37°C and 5% CO2  in Dulbecco's modified Eagle's
medium (ICN, Costa Mesa, CA, USA) supplemented with
10% (v/v) fetal calf serum (Gibco, Breda, Netherlands)
and penicillin/streptomycin. Transfection of HepG2 cells
with CAT-reporter constructs was performed by the cal-
cium-phosphate co-precipitation method. At 24 h before
transfection, the cells were plated in 6-wells plates at 20–
30 % confluence. At 3 h before transfection, the medium
was refreshed. Cells were co-transfected with 2.5 μg/well
of the CAT reporter test plasmid and 0.2 μg/well of control
RSV β-galactosidase expression plasmid (Promega) [36].
Parallel transfections with SV40-CAT-Control and empty
pCAT-Basic plasmids were used as controls. Fourty-eight
hours post-transfection, cell lysates were prepared. CAT
and β-galactosidase were determined by ELISA (Roche).
Promoter activity was expressed as pg CAT/ng β-galactosi-
dase to correct for differences in cell number and transfec-
tion efficiency.
Transfections of HepG2 and HeLa cells with the luci-
ferase-reporter constructs were performed in 24-wells
plates with Lipofectamine Plus (Invitrogen, Groningen,
Netherlands) using 0.4 μg of the luciferase-reporter con-
struct and 20 ng of pRL-CMV (Promega) per well [37].
Cell extracts were prepared at 48 h post-transfection. The
luciferase activity in the cell extracts was determined with
the FireLight kit (Perkin-Elmer, Boston MA, USA) and the
Packard Top Count NXT luminometer. Data were normal-
ized for the Renilla activity measured in the same sample.
Statistics
Experimental data are expressed as mean ± SD. Differ-
ences were tested for statistical significance by paired Stu-
dent's t-test.
List of abbreviations
CAT, chloramphenicol acetyltransferase; HDL, high-den-
sity lipoprotein; HL, hepatic lipase; HNF, hepatocyte
Table 2: Oligonucleotides used to generate serial 5'-deletions of the rat and human HL promoter region.
Name species and orientationa positionb 5'→3' sequencec
3F r F -1697/-1675 cggaagc TTA GCA GAC AGC GAT TGG C
4F r F -1048/-1030 cggaag CTT GCC TCC TCC TGA GTG C
5F r F -754/-736 cggaagc TTG TCC AGG GCG TCC ATA C
9F r F -211/-196 cggaagctt AGC TTG GCT CAA AAG G
8F r F -86/-71 cggaagctt GTG TTC AAA TAC TGG G
7F r F -75/-58 cggaagct TGG GTA ACA TGT TTT AGG
6F r F -39/-22 cggaag CTT CCA CAA CTA AAT ACC
11F r F -23/-8 cggaagctt CCA AGA AGC ATT CTG G
HHL-685Sac h F -685/-667 ccgagctc TGG TCG CCT TTT CCC TAC C
HHL-306Nhe h F -306/-291 gcatgctagc GAA GCC ACC TAC CCC G
HHL-79Kpn h F -79/-55 ggggtacc TAA CAT GTT GAG AGG
HHL-36Kpn h F -36/-20 ggggtac CAA AGT ATC TAA TAG GC
HHL+13Xba h R +13/-6 gctctaga CTT GGT AAT TTC TGA AGC C
HHL-10Kfw h F -10457/-10437 gtcgac GAA GGA TCA GGT GAG GGA TGG
HHL-10Krev h R -9956/-9975 ggatcc GCT TCA AGG GCA ATG AAA GC
HHL-14Kfw h F -14202/-14183 gtcgac GAC TTG GGG ATA TCC ACA TC
HHL-14Krev h R -13524/-13549 ggatc CTG GTA AAA GGA CAT GAA CAA TAT GG
HHL-22Kfw h F -21929/-21909 gtcgac GAT GGG AAA TGG ACC TAC AGC
HHL-22Krev h R -21543/-21562 ggatcc GAT GAG GAC TGA TTC TCA GC
CATREV2d - R gca act gac tga aat gcc tc
T3primere - R att aac cct cac taa ag
a: r and h: rat and human, respectively; F and R: forward and reverse orientation.
b: numbering of the rat and human sequence according to [35] and Ensembl e!42 [26], respectively.
c: rat and human HL specific parts of the primer sequences are given in capitals.
d: oligonucleotide specific for pCAT-Basic.
e: oligonucleotide specific for pBluescript.BMC Genomics 2007, 8:99 http://www.biomedcentral.com/1471-2164/8/99
Page 13 of 13
(page number not for citation purposes)
nuclear factor; kb, kilo basepairs; TFBS, transcription fac-
tor binding sites
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